NOS knockouts and neuroprotection.
Grünewald
T
T
Beal
M F
MF
D000818:Animals; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D020267:MPTP Poisoning / Q000150:complications / Q000201:enzymology; D051379:Mice; D018345:Mice, Knockout; D009410:Nerve Degeneration / Q000201:enzymology* / Q000209:etiology / Q000235:genetics; D018696:Neuroprotective Agents / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D010300:Parkinson Disease / Q000201:enzymology / Q000209:etiology / Q000235:genetics
D004791:Enzyme Inhibitors; D018696:Neuroprotective Agents; C496320:NOS1 protein, human; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; C496321:Nos1 protein, mouse; C496317:Nos2 protein, mouse